A Systematic Review on the Risk of Neurodegenerative Diseases and Neurocognitive Disorders in Professional and Varsity Athletes
Overview
Affiliations
Objective: The aim of this systematic review (SR) was to gather all available epidemiological evidence on former participation in any type of sport, at a professional and varsity level, as a potential risk factor for neurodegenerative diseases (NDs) and neurocognitive disorders (NCDs).
Design: Systematic searches were performed on PubMed, the Cochrane databases, and the ISI Web of Knowledge databases. Included studies were assessed using the NOS checklist.
Eligibility Criteria For Selecting Studies: All epidemiological studies reporting data on the possible association between a clinical diagnosis of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), dementia or mild cognitive impairment (MCI), Parkinson's disease (PD), chronic traumatic encephalopathy (CTE) at any stage and with any clinical pattern and the former participation in any types of sport at a varsity and professional level were included.
Results: Data from the 17 included studies showed a higher frequency of NDs and NCDs in former soccer and American football players. Updating the previous SR confirmed a higher frequency of ALS/MND in former soccer players. Data reported a significantly higher risk of dementia/AD in former soccer players, and of MCI in former American football players. Results also showed a significantly higher risk of PD in former soccer and American football players, and a significantly higher risk of CTE in former boxers and American football players. This SR confirmed a higher risk of NDs and NCDs in former professional/varsity athletes. However, the pathological mechanisms underlying this association remain unclear, and further high-quality studies should be performed to clarify whether the association could be sport specific.
Clinical implications of head trauma in frontotemporal dementia and primary progressive aphasia.
Asken B, Bove J, Bauer R, Tanner J, Casaletto K, Staffaroni A Alzheimers Res Ther. 2024; 16(1):193.
PMID: 39210451 PMC: 11363650. DOI: 10.1186/s13195-024-01553-1.
Johnson P, Fino P, Wilde E, Hovenden E, Russell H, Velez C Photobiomodul Photomed Laser Surg. 2024; 42(6):404-413.
PMID: 38848287 PMC: 11587703. DOI: 10.1089/pho.2023.0178.
The altered TBI fecal microbiome is stable and functionally distinct.
Pyles R, Miller A, Urban R, Sheffield-Moore M, Wright T, Maxwell C Front Mol Neurosci. 2024; 17:1341808.
PMID: 38544523 PMC: 10965628. DOI: 10.3389/fnmol.2024.1341808.
DSouza S, Milne B, Li C, Anns F, Gardner A, Lumley T BMJ Open Sport Exerc Med. 2024; 10(1):e001795.
PMID: 38362564 PMC: 10868174. DOI: 10.1136/bmjsem-2023-001795.
The amyotrophic lateral sclerosis exposome: recent advances and future directions.
Goutman S, Savelieff M, Jang D, Hur J, Feldman E Nat Rev Neurol. 2023; 19(10):617-634.
PMID: 37709948 PMC: 11027963. DOI: 10.1038/s41582-023-00867-2.